Sfoglia per AUTORE
RICHETTA AG
Collezione ASL Torino 4
Items : 2
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains-Should Psychosocial Life Impairment Be Considered a Comorbidity? in Journal of clinical medicine / J Clin Med. 2025 Jan 2;14(1):223. doi: 10.3390/jcm14010223.
2025
ASL Torino 4
ASL Torino 4
Licata G; Di Brizzi EV; Castelli F; Giuffrida G; Stroppiana E; Dattola A; Richetta AG; De Col E; Peila R; Siliquini N; Solaroli C; Zanetta R; Cerulli E; Galdo G; Giordano D; Faure E; Papaianni V; Pertusi G; Uzzauto MT; Loconsole F; Zichichi L;
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. in Patient preference and adherence / Patient Prefer Adherence. 2021 Nov 19;15:2551-2562. doi: 10.2147/PPA.S326498. eCollection 2021.
2021
ASL Alessandria
ASL Torino 4
ASL Alessandria
ASL Torino 4
Savoia P; Richetta AG; Peris K; Malara G; Loconsole F; Leporati C; Lembo S; Giofrè C; Foti C; Fargnoli MC; De Pasquale R; Costanzo A; Coppola S; Castelli G; Baggini G; Baldari M; Aragone MG; Amerio P; Argenziano G; Tiberio R; Travaglini M; Uzzauto MT; Bianchi L;